Q2 2024 Holdings
Filed 2024-08-14 | 18 holdings | $174.6M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Alimera Sciences Inc | COM NEW | 016259202 | $75.7M | 13,608,533 | 43.3% |
| Jasper Therapeutics Inc(JSPR) | COM NEW | 471871202 | $32.5M | 1,471,904 | 18.6% |
| Heron Therapeutics Inc(HRTX) | COM | 427746102 | $24.5M | 6,986,744 | 14.0% |
| Praxis Precision Medicines I(PRAX) | COM NEW | 74006W207 | $14.5M | 350,666 | 8.3% |
| Tourmaline BIO Inc(TRML) | COM | 89157D105 | $4.1M | 319,080 | 2.4% |
| Tela BIO Inc(TELA) | COM | 872381108 | $3.5M | 746,087 | 2.0% |
| Rezolute Inc(RZLT) | COM NEW | 76200L309 | $3.4M | 800,000 | 2.0% |
| Skye Bioscience Inc(SKYE) | COM NEW | 83086J200 | $3.4M | 422,142 | 1.9% |
| Optinose Inc | COM | 68404V100 | $2.6M | 2,492,830 | 1.5% |
| Context Therapeutics Inc(CNTX) | COM | 21077P108 | $2.6M | 1,290,323 | 1.5% |
| Inspiremd Inc(NSPR) | COM | 45779A846 | $2.3M | 904,029 | 1.3% |
| Outlook Therapeutics Inc(OTLK) | COM | 69012T305 | $1.8M | 247,084 | 1.0% |
| Elevation Oncology Inc | COM | 28623U101 | $1.6M | 597,299 | 0.9% |
| Protara Therapeutics Inc(TARA) | COM STK | 74365U107 | $998.4K | 480,000 | 0.6% |
| Kiora Pharmaceuticals Inc(KPRX) | COM | 49721T507 | $513.3K | 122,223 | 0.3% |
| X4 Pharmaceuticals Inc(ASNSUSD) | COM | 98420X103 | $382.2K | 659,020 | 0.2% |
| Aslan Pharmaceuticals LTD | SPON ADS NEW | 04522R200 | $187.5K | 625,000 | 0.1% |